Respiratory Infectious Disease Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Respiratory Infectious Disease Diagnostics Market was valued at USD 10.13 billion in 2020 and is projected to reach USD 18.23 billion by 2028, expanding at a CAGR of 8% during the forecast period, 2022 – 2028.

Diagnosis of respiratory infections mainly focuses on x-rays or CT scans to check for breathing problems and lower respiratory tract. Sometimes fluids and inflammation in the lungs are also examined. Respiratory infections are caused by viruses, bacteria, and other microorganisms that further infect the respiratory system, including the lungs, throat, and airways. Infection is often spread through mucus and saliva that are excreted when people sneeze, cough, or laugh. Few germs are transmitted through droplets that spread through the air and even through travel that causes respiratory infections. Some people can also become infected by touching microorganisms remaining on surfaces or by touching contaminated hands. Various respiratory infectious diseases include COVID-19 (COVID-19), Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS), Pneumonia, Influenza Disease, Tuberculosis, Pertussis (Pertussis), Enterobius, Chronic Obstructive Pulmonary Disease (COPD) ).

Market Segments

By Test Type

• Mechanical tests
• Imaging Tests
• In Vitro Diagnostics (IVD) Tests

By Disease Type

• Asthma
• Chronic Obstructive Pulmonary Disease
• Lung Cancer
• Tuberculosis
• Other Diseases

Key Players

The key players operating in this market include Abbott Laboratories, Thermo Fisher Scientific Inc., Alere, Inc., Koninklijke Philips N.V., Cardinal Health, COSMED, Smiths Group plc, NIHON KOHDEN CORPORATION, Becton, Dickinson and Company, and F. Hoffmann-La Roche AG.

Scope of the Report

The research study analyzes the global Respiratory Infectious Disease Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Respiratory Infectious Disease Diagnostics Market Report

1. What was the Respiratory Infectious Disease Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Respiratory Infectious Disease Diagnostics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Respiratory Infectious Disease Diagnostics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.